AVNET-MEMEC-SILICA
Avnet Memec - Silica, an Avnet, Inc. (NYSE: AVT) company, today announced the launch of the Visible ThingsTM platform for the development of Internet-of-Things (IoT) systems and applications. Targeting a wide range of industrial markets, Visible Things is a highly flexible and comprehensive evaluation and development platform for edge-to-enterprise IoT projects.
The platform delivers tested, proven, secure and integrated hardware and embedded software to connect smart sensors and embedded devices via gateway solutions or low-power wide-area networking technologies (LPWAN), right through to the cloud and enterprise software applications.
“With Visible Things we are one of the first distributors in the market offering a highly flexible edge-to-enterprise solution devoted to enable fast and easy development of industrial IoT applications,” said John Jones, director of innovation at Avnet Memec - Silica. “Unlike other supplier specific solutions which consist of a headline part with the rest of the building blocks left for the customer to optimise, Visible Things was developed based on best-in-class technology regarding function, cost and long term availability.”
The platform provides a unique set of benefits such as
- Fast deployment due to integrated and tested features
- Highest degree of flexibility with a range of smart sensor and connectivity options
- Simple ‘out of the box’ setup and experience
- Lowest power solution
- Size, cost, power and production optimised to closely match the end product
The platform supports short-range connectivity to a gateway, and Wi-Fi-, 3G and 4G cellular communications to the cloud and enterprise software applications. It also supports the SIGFOX and LoRaWAN IoT networks. These networks have been designed with specific features such as secure low-cost narrowband information messaging to meet the requirements of the IoT and smart city, machine-to-machine and industrial applications.
Avnet Memec - Silica will continue to augment the Visible Things IoT evaluation and development platform with new hardware and software technology options in the coming weeks and months, including a new chip that integrates a secure element for deployment in smart sensor edge devices.
Starter Kits
To help users get up and running quickly with their IoT project, there are three reference-design starter kit boards available at launch, each managed by ARM Cortex based microcontrollers:
The first kit comprises: a smart sensor board including Bluetooth Smart connectivity and a range of sensors including motion, temperature/humidity and light/proximity; a gateway board, which manages all the necessary connectivity to the cloud service via Wi-Fi; and a mini-USB cable. A GSM peripheral module with embedded SIM and SIM-connector options is available as an expansion option to the gateway board to enable cellular connectivity up to cloud enterprise software services. The starter kit is exclusively available from Avnet Memec - Silica now at a resale price of 199€.
The second and third kits are designed for use with the SIGFOX and LoRaWAN networks, and include respective SIGFOX and LoRaWAN module sensors, with each board also integrating additional motion and light sensors. IoT application messages can be exchanged with the cloud service without the need to communicate via a gateway.
Also available in the Visible Things platform is a mobile app that runs on iOS and Android and provides users with easy access to local hardware configuration and also supports connection to cloud services. The app also provides a quick start guide to make it simple to connect and configure the system from edge to enterprise.
Cloud Service
The Devicepoint cloud service is a key element of the Visible Things platform. Underpinned by IBM software components and run by partner company Spica Technologies, the Devicepoint cloud service builds upon data from sensors and edge devices with contextual information, plus data from other sources to deliver real-time analysis and long-term business intelligence. Connecting via the gateway, or directly to a SIGFOX or LoRaWAN network, the platform provides instant visualisation of sensor data in a simple standard cloud solution, allowing users to take appropriate action such as turning on actuators in industrial control systems. Further customisation is also available for the management of sensor data for analytics, reporting and workflow management.
More information can be found at www.avnetmemec-silica.com/visible-things .
About Avnet Memec - Silica
Avnet Memec - Silica is the European semiconductor specialist of Avnet, Inc., one of the leading global distributors. Customers may expect state-of-the-art technologies, comprehensive technical support and advanced supply chain and logistics services. Avnet Memec - Silica is a partner of leading semiconductor manufacturers and innovative solution providers over many years. With a team of more than 200 application engineers and technical specialists, Avnet Memec - Silica supports projects all the way from the idea to the concept to production. For more information, visit www.avnetmemec-silica.com .
View source version on businesswire.com: http://www.businesswire.com/news/home/20160225005019/en/
Contact:
Avnet Memec - Silica
Anja Woithe, +49 (0)8121 774-459
Senior
PR Manager Avnet EM EMEA
Anja.woithe@avnet.eu
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM31.8.2025 11:15:00 CEST | Press release
− Sustained Benefit of Vutrisiran Across Mortality, Cardiovascular Events, Quality of Life and Cardiac Biomarkers Observed Through Up to 48 Months, Including 12 Months from the Ongoing Open-Label Extension, Reinforce Potential as First-Line Treatment for ATTR-CM –− Vutrisiran, which Delivers Rapid Knockdown of Transthyretin, Reduced the Risk of Composite of All-Cause Mortality or First Cardiovascular Event by 37% in the Overall Population and 42% in the Monotherapy Group During the Same Period – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results of new analyses from the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic approved for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. Data from the 12-month follow-up of the ongoing open-label extension (OLE) period of HELIOS-B were presented during an oral session at the European Society of Card
WETEX Opens Broad Investment Horizons for International Companies31.8.2025 08:30:00 CEST | Press release
DEWA will organise the exhibition from 30 September to 2 October 2025 Under the directives of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, and the patronage of HH Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Supreme Council of Energy, Dubai Electricity and Water Authority (DEWA) will organise the 27th edition of the Water, Energy, Technology and Environment Exhibition (WETEX) from 30 September to 2 October 2025 at the Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250830023664/en/ WETEX opens broad investment horizons for international companies (Photo: AETOSWire) WETEX embodies the UAE's pioneering position in clean and renewable energy and sustainability. It also supports Dubai's ambitious vision of a sustainable economy. The exhibition covers multiple areas including water, energy, smart cities, green mobility, artificial i
Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C30.8.2025 18:00:00 CEST | Press release
Initiation of the development of new oral triple combination tablets, aimed at improving adherence and outcomes in low-density lipoprotein cholesterol (LDL-C) management. Recent findings from MILOS and SANTORINI registries presented at ESC Congress 2025, highlight ongoing challenges in accurately assessing cardiovascular (CV) risk and helping patients reach LDL-C targets.1-5 Furthermore, data from a four-country cohort of the MILOS study support the real-world effectiveness and safety of bempedoic acid in both sexes.6 Simulation using SANTORINI data reveals the potential of improved LDL-C goal attainment with tailored oral combination therapy of statins, ezetimibe and bempedoic acid, in line with the latest 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.7,8 Daiichi Sankyo has a long-standing commitment to easing treatment of cardiovascular disease (CVD) and exploring new treatment options that improve CVD outcomes and treatment adherence. Daiich
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial30.8.2025 16:30:00 CEST | Press release
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society of Cardiology Congress 2025 -- Zilebesiran Demonstrated Clinically Meaningful Reductions in Office Systolic Blood Pressure in Patients with Uncontrolled Hypertension and High Cardiovascular Risk at Month 3 Primary Endpoint, with Continuous Control Through Month 6 -- Zilebesiran Displayed Encouraging Safety When Combined with Two or More Antihypertensives -- Results Support Biannual Dosing Regimen and Inform Phase 3 Trial Design: Trial Expected to Initiate by Year-End 2025 -- Alnylam to Host Webcast Investor Event on August 30, 2025, at 1:00 pm ET (7:00 pm CEST) - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) to evaluate the potential of zilebesiran to reduce the risk of major adverse cardiovascular events. This decision is informed by results from t
Andersen Consulting styrker sine kompetencer inden for virksomhedstransformation med Fabric29.8.2025 17:01:00 CEST | Pressemeddelelse
Andersen Consulting udvider sin platform gennem en samarbejdsaftale med Fabric, der er et strategisk designfirma, der arbejder med organisationer for at integrere bæredygtighed, forsyningskæder og menneske-centreret innovation på tværs af kultur og drift. Fabric blev grundlagt i Japan i 2021 og arbejder sammen med virksomheder og globale brands om at skabe regenerative forretningsmodeller sammen samt bæredygtige brandstrategier og fremtidssikrede produkter. Ved hjælp af strategiske designmetoder og designfilosofi skaber virksomheden indsigtsbaseret transformation på tværs af forsyningskæder, brand og HR. Fabric er kendt for sin systemtænkning og sit engagement i social og miljømæssig bæredygtighed og fremmer desuden digitale transformationsinitiativer, der integrerer bæredygtighed, humankapital og AI. "Fabric er skabt for at hjælpe virksomheder med at blomstre gennem regenerative relationer til mennesker, samfund og forbundne, levende systemer," sagde James Hollow, der er grundlægger a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom